Medpace Holdings, Inc. P/E Ratio 2015–2025
Medpace Holdings, Inc. reported 36.76 of price-to-earnings ratio for fiscal 2025. That was 39.7% higher than fiscal 2024. Compared with fiscal 2020, the change was +1.4%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 36.76 | +39.7% |
| FY 2024 | 26.30 | -23.8% |
| FY 2023 | 34.52 | +18.3% |
| FY 2022 | 29.18 | -35.5% |
| FY 2021 | 45.25 | +24.8% |
| FY 2020 | 36.25 | +15.1% |
| FY 2019 | 31.48 | +17.2% |
| FY 2018 | 26.87 | -27.4% |
| FY 2017 | 37.00 | -62.0% |
| FY 2016 | 97.49 | — |
| FY 2015 | — | — |
Source: Medpace Holdings, Inc. SEC filings — fiscal-year-end price ÷ diluted EPS. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open MEDP 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Medpace Holdings, Inc. reported 36.76 of price-to-earnings ratio for fiscal 2025. That was 39.7% higher than fiscal 2024. Compared with fiscal 2020, the change was +1.4%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Medpace Holdings, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeMedpace Holdings, Inc. — frequently asked questions
What is Medpace Holdings, Inc.'s price-to-earnings ratio?
Medpace Holdings, Inc. (MEDP) reported price-to-earnings ratio of 36.76 for fiscal year 2025, per its SEC filings.
How has Medpace Holdings, Inc.'s price-to-earnings ratio changed over time?
Between fiscal 2015 and 2025, MEDP's price-to-earnings ratio declined at roughly 9.3% per year (compound annual rate), from 97.49 to 36.76.
Where does this data come from?
Figures are computed from Medpace Holdings, Inc.'s official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.
More MEDP financial history
Full MEDP fundamentals page → · Analyze price-to-earnings ratio with a free tool → · Research guide & leaders → · All 1,500+ companies →